Poster Session III. - K: Theoretical and Translational Medicine
Dr. Lénárt Ádám
WZU7TJ
Institute of Translational Medicine
06306309988
lenartadam15@gmail.com
The mechanosensory transient receptor potential vanilloid 4 mediates its effects through prostanoids in the urinary bladder
Ádám Lénárt1, Kinga Borsodi1, Helga Balla1, Péter József Molnár2, Bálint Dér2, Péter Nyirády3, Zoltán Benyó1
1: Institute of Translational Medicine
2: Institute of Translational Medicine, Department of Urology
3: Department of Urology
Poszter
Poster Session III. - K: Theoretical and Translational Medicine
English
Theoretical and Translational Medicine
Introduction: Mechanotransduction, where ion channels sense bladder filling, is a key regulator of normal urinary bladder function. Upon reaching a certain wall tension, signaling pathways are activated, leading to the urge to urinate. The transient receptor potential vanilloid type 4 (TRPV4) channel is a major mechanosensory component in this process. Conditions like overactive bladder syndrome, characterized by frequent and urgent urination, are thought to involve altered mechanotransduction. However, the detailed mechanisms are still not fully understood. Our goal was to study TRPV4-mediated bladder signaling to identify possible new therapeutic targets.
Methods: Experiments were conducted on adult male and female wild-type and cyclooxygenase 1 knock-out (COX1-KO) mice. Bladder function was assessed in vivo by transurethral cystometry and ex vivo by myography. Mediator levels were measured using ELISA kits.
Results: TRPV4 activation significantly enhanced bladder activity, an effect almost entirely abolished by the non-selective COX inhibitor indomethacin both in vivo and ex vivo. In COX1-KO mice, the effect was partially reduced, while in the presence of a COX2 inhibitor, it was fully eliminated. Levels of Prostaglandin E2 and Thromboxane A2, both COX products, rose significantly 5 minutes after TRPV4 activation and further increased after 10 minutes.
Conclusions: TRPV4 activation in the bladder wall triggers inflammatory mediator production, leading to increased bladder excitability through mainly local processes. Both COX1 and COX2 enzymes contribute to mediator production. We identified a signaling pathway where multiple intervention points could reduce bladder overactivity. These findings may aid the development of more targeted therapies for functional urological conditions associated with bladder hyperactivity.
Support: Hungarian NRDIO K-112964, K-125174, K-135683, K-139230, and EFOP-3.6.3-VEKOP-16-2017-00009 grants, 2024-2.1.1-EKÖP
Semmelweis University
Prof Dr. Zoltán Benyó
I do not give consent to the publication of my abstract on the website of the congress.
in doctoral studies after complex exam (PhD)
Szabad
elfogadva
poszter
nem rendelkezett róla
8254
14:18
14:24